ESSA Pharma Inc Cash Flow-to-Debt Ratio
ESSA Pharma Inc cash flow-to-debt ratio. ESSA Pharma Inc (EPIX) has a Cash Flow-to-Debt Ratio of -2.63x as of June 2025, meaning its operating cash flow of $-4.20 Million could theoretically repay -3% of its total liabilities ($1.60 Million) in one year. Check ESSA Pharma Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ESSA Pharma Inc (2012–2024)
Cash flow-to-debt ratio of ESSA Pharma Inc from 2012 to 2024. Historical debt coverage capacity for ESSA Pharma Inc across 13 annual periods. Check EPIX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
ESSA Pharma Inc Cash Flow-to-Debt Ratio by Year (2012–2024)
ESSA Pharma Inc cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for ESSA Pharma Inc. For the full cash flow conversion analysis, see ESSA Pharma Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -6.48x | $-22.72 Million | $3.51 Million | ▼ -14.5% |
| 2023 | -5.66x | $-19.78 Million | $3.50 Million | ▲ +52.9% |
| 2022 | -12.03x | $-28.70 Million | $2.39 Million | ▼ -96.8% |
| 2021 | -6.11x | $-25.42 Million | $4.16 Million | ▲ +52.1% |
| 2020 | -12.76x | $-16.98 Million | $1.33 Million | ▼ -482.6% |
| 2019 | -2.19x | $-12.25 Million | $5.59 Million | ▼ -47.2% |
| 2018 | -1.49x | $-10.22 Million | $6.87 Million | ▲ +15.3% |
| 2017 | -1.76x | $-17.35 Million | $9.88 Million | ▼ -25.6% |
| 2016 | -1.40x | $-15.30 Million | $10.94 Million | ▲ +65.1% |
| 2015 | -4.01x | $-12.30 Million | $3.07 Million | ▼ -329.5% |
| 2014 | -0.93x | $-2.08 Million | $2.23 Million | ▼ -21848.8% |
| 2013 | 0.00x | $-763.35 | $179.34K | ▲ +100.0% |
| 2012 | -13.71x | $-1.82K | $133.04 | — |